Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
In the first five months of this year, shipments of pharma products from Ireland to the United States were up nearly fourfold compared with the same period in 2024.
Simplified Text
Shipments of pharma products from Ireland to the United States were up nearly fourfold in the first five months of 2025 compared with the same period in 2024.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "location": "Ireland",
    "timeframe": "First five months of 2025",
    "destination": "United States",
    "product_type": "Pharmaceuticals",
    "comparison_timeframe": "Same period in 2024"
}
Subject Tags
Health Business Economic
UUID
9fdb5db9-af64-48b2-a59c-44884a78ed12
Vector Index
✗ No vector
Created
September 12, 2025 at 2:46 AM (2 days ago)
Last Updated
September 12, 2025 at 2:46 AM (2 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games
Pending
News
41 claims 🔥
2 days ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337

US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs
Corporate Tax Avoidance

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP